Generation of a Biomimetic Substitute of the Corneal Limbus Using Decellularized Scaffolds.

dc.contributor.authorSánchez-Porras, David
dc.contributor.authorCaro-Magdaleno, Manuel
dc.contributor.authorGonzález-Gallardo, Carmen
dc.contributor.authorGarcía-García, Óscar Darío
dc.contributor.authorGarzón, Ingrid
dc.contributor.authorCarriel, Víctor
dc.contributor.authorCampos, Fernando
dc.contributor.authorAlaminos, Miguel
dc.date.accessioned2025-01-07T14:04:05Z
dc.date.available2025-01-07T14:04:05Z
dc.date.issued2021-10-17
dc.description.abstractPatients with severe limbal damage and limbal stem cell deficiency are a therapeutic challenge. We evaluated four decellularization protocols applied to the full-thickness and half-thickness porcine limbus, and we used two cell types to recellularize the decellularized limbi. The results demonstrated that all protocols achieved efficient decellularization. However, the method that best preserved the transparency and composition of the limbus extracellular matrix was the use of 0.1% SDS applied to the half-thickness limbus. Recellularization with the limbal epithelial cell line SIRC and human adipose-derived mesenchymal stem cells (hADSCs) was able to generate a stratified epithelium able to express the limbal markers p63, pancytokeratin, and crystallin Z from day 7 in the case of SIRC and after 14-21 days of induction when hADSCs were used. Laminin and collagen IV expression was detected at the basal lamina of both cell types at days 14 and 21 of follow-up. Compared with control native limbi, tissues recellularized with SIRC showed adequate picrosirius red and alcian blue staining intensity, whereas limbi containing hADSCs showed normal collagen staining intensity. These preliminary results suggested that the limbal substitutes generated in this work share important similarities with the native limbus and could be potentially useful in the future.
dc.identifier.doi10.3390/pharmaceutics13101718
dc.identifier.issn1999-4923
dc.identifier.pmcPMC8541096
dc.identifier.pmid34684011
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8541096/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/1999-4923/13/10/1718/pdf?version=1634787663
dc.identifier.urihttps://hdl.handle.net/10668/26107
dc.issue.number10
dc.journal.titlePharmaceutics
dc.journal.titleabbreviationPharmaceutics
dc.language.isoen
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectcorneal limbus
dc.subjectdecellularized xenograft
dc.subjectmesenchymal stem cells
dc.subjectrecellularization
dc.titleGeneration of a Biomimetic Substitute of the Corneal Limbus Using Decellularized Scaffolds.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number13

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC8541096.pdf
Size:
7.32 MB
Format:
Adobe Portable Document Format